Supporting this idea Rozovski, Grgurevic, et al. demonstrated that LPL confers CLL a survival advantage, since shRNA knockdown of LPL increases apoptotic death [36]. This evidence concerns the gene LPL and B-cell chronic lymphocytic leukemia.